322 related articles for article (PubMed ID: 12946542)
21. Pharmacological treatment of congestive heart failure in Canada: a description of care in five provinces.
Cox JL; Ramer SA; Lee DS; Humphries K; Pilote L; Svenson L; Tu JV;
Can J Cardiol; 2005 Mar; 21(4):337-43. PubMed ID: 15838560
[TBL] [Abstract][Full Text] [Related]
22. Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors.
Gheorghiade M; Hall VB; Jacobsen G; Alam M; Rosman H; Goldstein S
Circulation; 1995 Oct; 92(7):1801-7. PubMed ID: 7671364
[TBL] [Abstract][Full Text] [Related]
23. Contemporary medical management of left ventricular dysfunction and congestive heart failure.
Teo KK; Ignaszewski AP; Gutierrez R; Hill KL; Martin SL; Calhoun HP; Humen DP; Montague TJ
Can J Cardiol; 1992; 8(6):611-9. PubMed ID: 1354569
[TBL] [Abstract][Full Text] [Related]
24. Prescribing and emergency admissions for heart failure in greater Glasgow.
Davie AP; Morrison CE; Forrester JE; Mcmurray JJ
J Card Fail; 1999 Mar; 5(1):3-7. PubMed ID: 10194654
[TBL] [Abstract][Full Text] [Related]
25. Digoxin remains useful in the management of chronic heart failure.
Dec GW
Med Clin North Am; 2003 Mar; 87(2):317-37. PubMed ID: 12693728
[TBL] [Abstract][Full Text] [Related]
26. Congestive heart failure in the elderly. The therapeutic challenge of atypical presentations.
Gupta SC
Postgrad Med; 1991 Nov; 90(7):83-7. PubMed ID: 1946122
[TBL] [Abstract][Full Text] [Related]
27. Increased plasma level of substance P in patients with severe congestive heart failure treated with ACE inhibitors.
Valdemarsson S; Edvinsson L; Ekman R; Hedner P; Sjöholm A
J Intern Med; 1991 Oct; 230(4):325-31. PubMed ID: 1717629
[TBL] [Abstract][Full Text] [Related]
28. Nonselective beta-adrenergic blockade with carvedilol does not hinder the benefits of exercise training in patients with congestive heart failure.
Demopoulos L; Yeh M; Gentilucci M; Testa M; Bijou R; Katz SD; Mancini D; Jones M; LeJemtel TH
Circulation; 1997 Apr; 95(7):1764-7. PubMed ID: 9107160
[TBL] [Abstract][Full Text] [Related]
29. Plasma concentration of Fas/Fas ligand and left ventricular function in response to metoprolol in conjunction with standard treatment.
Hou YP; Wu JL; Fan Q; Liu MB; Yin BL; Zhang L
Clin Sci (Lond); 2007 Mar; 112(5):299-304. PubMed ID: 17020540
[TBL] [Abstract][Full Text] [Related]
30. Review of randomized trials of digoxin therapy in patients with chronic heart failure.
Gheorghiade M; Zarowitz BJ
Am J Cardiol; 1992 Jun; 69(18):48G-62G; discussion 62G-63G. PubMed ID: 1626492
[TBL] [Abstract][Full Text] [Related]
31. Underutilisation of ACE inhibitors in patients with congestive heart failure.
Bungard TJ; McAlister FA; Johnson JA; Tsuyuki RT
Drugs; 2001; 61(14):2021-33. PubMed ID: 11735631
[TBL] [Abstract][Full Text] [Related]
32. A review of heart failure management in the elderly population.
Cheng JW; Nayar M
Am J Geriatr Pharmacother; 2009 Oct; 7(5):233-49. PubMed ID: 19948300
[TBL] [Abstract][Full Text] [Related]
33. Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. V-HeFT III investigators.
Boden WE; Ziesche S; Carson PE; Conrad CH; Syat D; Cohn JN
Am J Cardiol; 1996 May; 77(12):1078-82. PubMed ID: 8644661
[TBL] [Abstract][Full Text] [Related]
34. National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure.
Stafford RS; Saglam D; Blumenthal D
Arch Intern Med; 1997 Nov; 157(21):2460-4. PubMed ID: 9385297
[TBL] [Abstract][Full Text] [Related]
35. [The main aspects of symptomatic therapy of chronic heart failure].
Zaliaduonyte-Peksiene D; Mikuckaite L; Kavoliūniene A
Medicina (Kaunas); 2006; 42(11):949-55. PubMed ID: 17172798
[TBL] [Abstract][Full Text] [Related]
36. [Drug treatment of cardiac insufficiency with systolic dysfunction].
Follath F
Praxis (Bern 1994); 1997 Feb; 86(7):254-7. PubMed ID: 9139344
[TBL] [Abstract][Full Text] [Related]
37. Does digoxin still have a role in congestive heart failure?
Kothari SS
Indian J Pediatr; 1997; 64(6):833-7. PubMed ID: 10771927
[TBL] [Abstract][Full Text] [Related]
38. Temporal patterns in the medical treatment of congestive heart failure with angiotensin-converting enzyme inhibitors in older adults, 1989 through 1995.
Smith NL; Psaty BM; Pitt B; Garg R; Gottdiener JS; Heckbert SR
Arch Intern Med; 1998 May; 158(10):1074-80. PubMed ID: 9605778
[TBL] [Abstract][Full Text] [Related]
39. Current concepts in clinical therapeutics: congestive heart failure.
Klamerus KJ
Clin Pharm; 1986 Jun; 5(6):481-98. PubMed ID: 2872992
[TBL] [Abstract][Full Text] [Related]
40. Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).
Massie BM; Berk MR; Brozena SC; Elkayam U; Plehn JF; Kukin ML; Packer M; Murphy BE; Neuberg GW; Steingart RM
Circulation; 1993 Aug; 88(2):492-501. PubMed ID: 8339411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
